177 related articles for article (PubMed ID: 20156804)
1. Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.
Morales FC; Molina JR; Hayashi Y; Georgescu MM
Neuro Oncol; 2010 Jun; 12(6):528-39. PubMed ID: 20156804
[TBL] [Abstract][Full Text] [Related]
2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic role of Merlin/NF2 in glioblastoma.
Guerrero PA; Yin W; Camacho L; Marchetti D
Oncogene; 2015 May; 34(20):2621-30. PubMed ID: 25043298
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p.
Lee H; Hwang SJ; Kim HR; Shin CH; Choi KH; Joung JG; Kim HH
Biochim Biophys Acta; 2016 Apr; 1859(4):599-611. PubMed ID: 26923924
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma.
Beltrami S; Branchetti E; Sariyer IK; Otte J; Weaver M; Gordon J
PLoS One; 2013; 8(1):e53447. PubMed ID: 23308224
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
[TBL] [Abstract][Full Text] [Related]
7. Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
Laulajainen M; Melikova M; Muranen T; Carpén O; Grönholm M
J Cell Mol Med; 2012 Sep; 16(9):2161-75. PubMed ID: 22325036
[TBL] [Abstract][Full Text] [Related]
8. Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function.
Moesslacher CS; Auernig E; Woodsmith J; Feichtner A; Jany-Luig E; Jehle S; Worseck JM; Heine CL; Stefan E; Stelzl U
Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37280085
[TBL] [Abstract][Full Text] [Related]
9. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
11. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).
Tikoo A; Varga M; Ramesh V; Gusella J; Maruta H
J Biol Chem; 1994 Sep; 269(38):23387-90. PubMed ID: 8089100
[TBL] [Abstract][Full Text] [Related]
12. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
[TBL] [Abstract][Full Text] [Related]
14. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
[TBL] [Abstract][Full Text] [Related]
15. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
[TBL] [Abstract][Full Text] [Related]
16. The merlin interacting proteins reveal multiple targets for NF2 therapy.
Scoles DR
Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
[TBL] [Abstract][Full Text] [Related]
18. NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
Chiasson-MacKenzie C; Morris ZS; Baca Q; Morris B; Coker JK; Mirchev R; Jensen AE; Carey T; Stott SL; Golan DE; McClatchey AI
J Cell Biol; 2015 Oct; 211(2):391-405. PubMed ID: 26483553
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
20. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
Johnson KC; Kissil JL; Fry JL; Jacks T
Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
